M&A Deal Summary |
|
|---|---|
| Date | 2024-04-18 |
| Target | Stirling Ultracold |
| Sector | Medical Products |
| Buyer(s) | GCI Holdings |
| Sellers(s) | BioLife Solutions |
| Deal Type | Divestiture |
SEARCH BY
GCI Holdings is a holding company based in Ohio.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Employees | 159 |
| Revenue | 82M USD (2024) |
BioLife Solutions is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. Our biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. BioLife Solutions was founded in 1987 and is based in Bothell, Washington.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 4 |
| State: Ohio M&A | 1 of 1 |
| Country: United States M&A | 1 of 4 |
| Year: 2024 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-09 |
Sexton Biotechnologies
Indianapolis, Indiana, United States Sexton Biotechnologies is a revenue-stage, biotechnology company focused on the development and sales of bioproduction tools for cell and gene therapy. Sexton develops purpose-built cell and gene therapy (CGT) tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points and labor costs. Sexton Biotechnologies Indianapolis is based in Indianapolis, Indiana. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-11-12 |
SciSafe
Cranbury, New Jersey, United States SciSafe is a provider of biological materials storage to the cell and gene therapy and pharmaceutical industries. SciSafe was established in 2010 and is based in Cranbury, New Jersey. |
Sell | $73M |
